AU7350798A - Corona virus-like particles as tools for vaccination and therapy - Google Patents

Corona virus-like particles as tools for vaccination and therapy

Info

Publication number
AU7350798A
AU7350798A AU73507/98A AU7350798A AU7350798A AU 7350798 A AU7350798 A AU 7350798A AU 73507/98 A AU73507/98 A AU 73507/98A AU 7350798 A AU7350798 A AU 7350798A AU 7350798 A AU7350798 A AU 7350798A
Authority
AU
Australia
Prior art keywords
vaccination
therapy
tools
particles
corona virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73507/98A
Inventor
Petrus Josephus Marie Rottier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rijksuniversiteit Utrecht
Original Assignee
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit Utrecht filed Critical Rijksuniversiteit Utrecht
Publication of AU7350798A publication Critical patent/AU7350798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/20045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/609—Vectors comprising as targeting moiety peptide derived from defined protein from viruses positive strand RNA viruses
AU73507/98A 1997-04-29 1998-04-29 Corona virus-like particles as tools for vaccination and therapy Abandoned AU7350798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201292 1997-04-29
EP97201292 1997-04-29
PCT/NL1998/000237 WO1998049195A1 (en) 1997-04-29 1998-04-29 Corona virus-like particles as tools for vaccination and therapy

Publications (1)

Publication Number Publication Date
AU7350798A true AU7350798A (en) 1998-11-24

Family

ID=8228281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73507/98A Abandoned AU7350798A (en) 1997-04-29 1998-04-29 Corona virus-like particles as tools for vaccination and therapy

Country Status (2)

Country Link
AU (1) AU7350798A (en)
WO (1) WO1998049195A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE362990T1 (en) * 1999-06-30 2007-06-15 Evotec Ag VIRUS-LIKE PARTICLES, PREPARATION AND USE IN SCREENING AND FUNCTIONAL GENOME APPLICATION
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
JP4085231B2 (en) 2000-02-28 2008-05-14 株式会社ビークル Protein hollow nanoparticles, substance carrier using the same, and method for introducing substance into cells
EP1219705B1 (en) * 2000-12-29 2007-11-28 Evotec AG Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US7556957B2 (en) 2001-05-17 2009-07-07 Stichting Voor De Technische Wetenschappen Coronavirus-like particles comprising functionally deleted genomes
DE60236965D1 (en) * 2001-05-17 2010-08-19 Univ Utrecht CORONAVIRUS-SIMILAR PARTICLES CONTAINING FUNCTIONALLY DELETED GENOME
EP2196217A1 (en) 2001-09-14 2010-06-16 Cytos Biotechnology AG Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
DK1610817T3 (en) * 2003-03-03 2010-01-25 Intervet Int Bv Infectious bronchitis virus with an altered spike gene
CA2517839A1 (en) 2003-03-26 2004-10-07 Martin F. Bachmann Melan-a peptide analogue-virus-like-particle conjugates
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
CN1223605C (en) * 2003-05-16 2005-10-19 中国科学院微生物研究所 Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof
SG152020A1 (en) * 2003-08-06 2009-05-29 Nat Environment Agency Diagnostic methods
JP2008521384A (en) * 2004-11-26 2008-06-26 達梭生技医葯股▲ふん▼有限公司 An expression vector encoding a coronavirus-like particle
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
CA2655108C (en) 2006-06-12 2019-05-07 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
WO2008073960A2 (en) 2006-12-12 2008-06-19 Integrated Dna Technologies, Inc. Oligonucleotides containing high concentrations of guanine monomers
BR112013022011A2 (en) 2011-03-02 2016-11-16 Intervet Int Bv infectious bronchitis virus spike protein or an immunogenic fragment thereof, protein structure, DNA molecule, plasmid, avian live recombinant carrier virus, vaccine, and mammalian cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003537A1 (en) * 1990-08-15 1992-03-05 Therion Biologics Corporation Self-assembling replication defective hybrid virus particles
WO1993005147A1 (en) * 1991-08-30 1993-03-18 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Defective interfering hiv particles with chimeric cd4-env
ZA937164B (en) * 1992-09-28 1994-05-23 Commw Scient Ind Res Org Delivery system
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease

Also Published As

Publication number Publication date
WO1998049195A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU7350798A (en) Corona virus-like particles as tools for vaccination and therapy
AU1308495A (en) Influenza vaccine
AU4378899A (en) Apparatus and method relating to charged particles
AU9623898A (en) Vaccines
ZA986368B (en) Apparatus and methods for pulverizing materials into small particles
AU4781297A (en) Vaccines
AU6884798A (en) Acoustic respiratory therapy apparatus
AU5337796A (en) Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
AUPO206596A0 (en) Tool grinding simulation system
AU3098097A (en) Virus-like particles useful as a vector delivering nucleic acid
AU7694796A (en) Tumour vaccine and processes for preparing it
AU7704498A (en) Human frp and fragments thereof including methods for using them
AU5874798A (en) Vaccination methods and molecules
GB9420146D0 (en) Papillomavirus vaccine
AU2633199A (en) Anti-angiogenic vaccines: substances and methods relating thereto
AU5333298A (en) Compositions and methods for tumour therapy
AU4450696A (en) Enhanced immunogenic vaccine
AU2572597A (en) Virus-like particle
AU3038697A (en) Meningococcal vaccine
AU6300898A (en) Well treatment with particles
AU3552797A (en) Vaccine preparations
AU8382198A (en) Methods for inactivating enveloped rna virus particles and compositions for use therewith
AU4272996A (en) Means for treatment of particle mass
AU1829097A (en) Methods for regenerating scarless skin and compositions used therein
AU6922198A (en) Method for gelling aqueous media, use of copolyesters as gelling agents of aqueous media and novel copolyesters for gelling aqueous media

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase